Home » Topics » Disease categories and therapies » Infection

Infection
RSS

FDA approves expanded indications for Dynabac

March 6, 1998

New introduction for Glaxo Wellcome/Otsuka broad-spectrum fluoroquinolone

March 5, 1998

Liposomal ciprofloxacin formulations demonstrate high efficacy and versatility

March 4, 1998

Efficacy of immunoliposomal amphotericin B confirmed in mice with invasive aspergillosis

March 4, 1998

CFC-222 compared to other fluoroquinolones in vitro and in vivo

March 3, 1998

Lilly glycopeptide antibiotic compared to vancomycin and teicoplanin in vitro

March 2, 1998

Pharmacodynamics of HMR-3647 against respiratory pathogens, enterococci and B. fragilis

March 2, 1998

Novel antiviral agents from Lilly

March 2, 1998

Patent coverage for ProLease interferon

Feb. 27, 1998

Beta-lactams with dual beta-lactamase-inhibitory/antibacterial activity from Roche

Feb. 27, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...